UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. __)
COLE NATIONAL CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
193290103
- --------------------------------------------------------------------------------
(CUSIP Number)
Gary P. Kreider, Esq.
Keating, Muething & Klekamp, P.L.L.
1400 Provident Tower
One East Fourth Street
Cincinnati, Ohio 45202
(513)579-6411
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number
of Person Authorized to Receive Notices and Communications)
August 26, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [ ].
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP No. 193290103
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Stephen N. Joffe, M. D.
- --------------------------------------------------------------------------------
2 CHECK BOX IF A MEMBER OF A GROUP (a) [x]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS *
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ----------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 1,000,000 - See Item 5.I(b)
WITH ----------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
750,000
----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,000,000
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,000,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11);
6.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP No. 193290103
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Sandra F. W. Joffe
- --------------------------------------------------------------------------------
2 CHECK BOX IF A MEMBER OF A GROUP (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS *
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY --------------------------------------------------------------
EACH 8 SHARED VOTING POWER
REPORTING
PERSON 1,000,000 - See Item 5.II(b)
WITH --------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
250,000
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,000,000
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,000,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11);
6.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
Item 1. Security and Issuer
This statement relates to shares of common stock, par value $0.001 per
share, of Cole National Corporation, a Delaware corporation having its principal
executive offices at 5915 Landerbrook Drive, Mayfield Heights, Ohio 44124.
Item 2. Identity and Background
(a) This statement is being filed on behalf of Stephen N. Joffe, M.D.
and his wife, Sandra F. W. Joffe
(b) The business address of the Joffes is 7840 Montgomery Road,
Cincinnati, Ohio 45236.
(c) Dr. Joffe serves as the Chairman of the Board and Chief Executive
Officer of LCA-Vision Inc. Mrs. Joffe serves as the Secretary of
LCA-Vision Inc. LCA-Vision Inc.'s address is 7840 Montgomery
Road, Cincinnati, Ohio 45236.
(d) Neither of the Joffes has been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors) during the
last five years.
(e) Neither of the Joffes has during the last five years been a party
to a civil proceeding of a judicial or administrative body of
competent jurisdiction nor as a result of such proceeding were
they or are they subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or
finding any violation with respect to such laws.
(f) The Joffes are United States citizens.
Item 3. Source and Amount of Funds or Other Consideration
The Joffes have used personal funds in connection with acquisitions to date
of such Cole National Corporation common stock.
Item 4. Purpose of Transaction
The Joffes have acquired their beneficial ownership in the shares of Cole
National Corporation common stock for investment purposes. The Joffes may
purchase additional shares of common stock in the open market or in private
transactions or sell any or all of their shares of common stock.
<PAGE>
Other than as set forth above, the Joffes have no plans or proposals which
would relate to or result in actions under any of the following paragraphs of
Item 4 of Schedule 13D:
(a) the acquisition by any person of additional securities of the
Company, or the disposition of securities of the Company;
(b) an extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Company or any of
its subsidiaries;
(c) a sale or transfer of a material amount of assets of the Company
or any of its subsidiaries;
(d) any change in the present board of directors or management of the
Company, including any plans or proposals to change the number or
term of directors or to fill any existing vacancies on the board;
(e) any material change in the present capitalization or dividend
policy of the Company;
(f) any other material change in the Company's business or corporate
structure;
(g) changes in the Company's articles of incorporation or by-laws or
other actions which may impede the acquisition of control of the
Company by any person;
(h) causing a class of securities of the Company to cease to be
authorized to be quoted in an inter-dealer quotation system of a
registered national securities association; or
(i) a class of equity securities of the Company becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the
Securities Exchange Act of 1934; or
(j) any action similar to any of those enumerated above.
Item 5. Interest in Securities of the Issuer
I. Dr. Joffe
(a) See page 2, nos. 11 and 13.
(b) See page 2, nos. 7-10.
(c) All of the following trades were made through market
transactions during the last sixty days:
<PAGE>
Date Purchase or Sale Number of Shares Price Per Share
---- ---------------- ---------------- ---------------
07/22/99 Purchase 1,500 $8.06
07/22/99 Purchase 5,000 8.00
07/22/99 Purchase 2,500 8.00
07/22/99 Purchase 2,500 8.00
07/22/99 Purchase 2,500 8.13
07/22/99 Purchase 2,500 8.13
07/22/99 Purchase 3,000 8.19
07/22/99 Purchase 1,500 8.19
07/22/99 Purchase 1,500 8.25
07/22/99 Purchase 1,500 8.25
07/22/99 Purchase 4,500 8.44
07/26/99 Purchase 2,500 8.00
07/26/99 Purchase 2,500 8.00
07/26/99 Purchase 5,000 8.00
07/26/99 Purchase 5,000 8.00
07/26/99 Purchase 5,000 8.00
07/26/99 Purchase 5,000 8.00
07/26/99 Purchase 5,000 8.00
07/26/99 Purchase 5,000 8.00
07/26/99 Purchase 5,000 8.00
07/26/99 Purchase 10,000 8.00
07/26/99 Purchase 10,000 8.00
07/26/99 Purchase 10,000 8.00
07/26/99 Purchase 10,000 8.00
<PAGE>
07/26/99 Purchase 10,000 8.00
07/26/99 Purchase 10,000 8.00
07/26/99 Purchase 10,000 8.00
07/26/99 Purchase 10,000 8.00
07/27/99 Purchase 2,400 8.00
07/27/99 Purchase 5,800 8.13
07/27/99 Purchase 10,000 8.06
07/28/99 Purchase 600 8.00
07/28/99 Purchase 3,200 8.06
07/28/99 Purchase 9,500 8.19
07/28/99 Purchase 5,600 8.19
07/29/99 Purchase 2,400 8.13
07/30/99 Purchase 5,000 8.13
07/30/99 Purchase 5,600 8.13
07/30/99 Purchase 2,000 8.13
07/30/99 Purchase 1,400 8.13
08/02/99 Purchase 10,000 8.00
08/02/99 Purchase 5,700 8.06
08/03/99 Purchase 6,100 8.06
08/03/99 Purchase 3,000 8.00
08/03/99 Purchase 1,000 8.00
08/03/99 Purchase 2,900 8.06
08/10/99 Purchase 3,300 8.06
08/11/99 Purchase 5,000 8.06
08/11/99 Purchase 6,000 8.06
08/12/99 Purchase 20,000 8.50
<PAGE>
08/12/99 Purchase 15,000 8.50
08/12/99 Purchase 15,000 8.50
08/12/99 Purchase 10,000 8.50
08/12/99 Purchase 50,000 8.38
08/13/99 Purchase 150,000 8.25
08/16/99 Purchase 100,000 8.13
08/24/99 Purchase 125,000 8.06
08/26/99 Purchase 10,000 8.06
08/26/99 Purchase 10,000 8.06
(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the
proceeds from the sale of, the securities referred to in
Item 5.I(a).
(e) Not applicable.
II. Mrs. Joffe
(a) See page 3, nos. 11 and 13.
(b) See page 3, nos. 7-10.
(c) All of the following trades were made through market
transactions during the last sixty days:
Date Purchase or Sale Number of Shares Price Per Share
---- ---------------- ---------------- ---------------
09/01/99 Purchase 107,900 $7.44
09/07/99 Purchase 142,100 7.81
(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the
proceeds from the sale of, the securities referred to in
Item 5.II(a).
(e) Not applicable.
<PAGE>
Item 6. Contracts, Arrangements, Understandings, and Relationships with
Respect to Securities of the Issuer
None.
Item 7. Material Required to be Filed as Exhibits
Exhibit 10 Agreement required pursuant to Regulation Section
240.13d-1(f)(1) promulgated under the Securities
Exchange Act of 1934
Exhibit 24.1 Power of Attorney for Dr. Joffe
Exhibit 24.2 Power of Attorney for Mrs. Joffe
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of their respective knowledge and
belief, the undersigned certify that the information set forth in this Statement
is true, complete, and correct.
September 8, 1999 /s/ Stephen N. Joffe
---------------------------
Stephen N. Joffe
/s/ Sandra F.W. Joffe
---------------------------
Sandra F.W. Joffe
EXHIBIT 10
AGREEMENT
This Agreement ("Agreement") executed this 8th day of September, 1999 is by
and among Stephen N. Joffe, M.D. and Sandra F.W. Joffe (collectively, the
"Shareholders").
WHEREAS, as of the date of this Agreement, the Shareholders own
approximately [6.7]% of the common stock (the "Common Stock"), of Cole National
Corporation, a Delaware corporation;
WHEREAS, the Shareholders may be deemed to be the beneficial owners of the
Common Stock pursuant to Regulation Section 240.13d-3 promulgated under the
Securities Exchange Act of 1934; and
WHEREAS, the Shareholders from time to time must file statements pursuant
to certain sections of the Securities Exchange Act of 1934 concerning their
ownership of Common Stock.
NOW, THEREFORE, in consideration of the premises the Shareholders agree:
1. That the Shareholders do hereby agree to file jointly with the
Securities Exchange Commission any schedules or other filings or amendments
thereto made by or on behalf of the Shareholders pursuant to Section 13(d) of
the Securities Exchange Act of 1934.
2. That Dr. Joffe shall, in consultation with Mrs. Joffe, have the
authority to make all decisions regarding the matters which are the subject of
their ownership of the shares of Cole National Corporation covered by a Schedule
13D filed with the Securities and Exchange Commission.
3. This Agreement shall be governed in accordance with the laws of Ohio,
may be amended only in writing and may be terminated by either party upon ten
days written notice. In the event of termination, each party shall remain liable
for his or her shares of the expenses incurred to the date of termination and
shall promptly pay their share of expenses, upon receipt of invoice, to the
remaining party.
IN WITNESS WHEREOF, the parties have executed this Agreement on the date
set forth above.
/s/ Stephen N. Joffe
---------------------------
Stephen N. Joffe
/s/ Sandra F.W. Joffe
---------------------------
Sandra F.W. Joffe
EXHIBIT 24.1
POWER OF ATTORNEY
I, STEPHEN N. JOFFE, hereby appoint GARY P. KREIDER or F. MARK REUTER, or
either of them, as my true and lawful attorney-in-fact to sign on my behalf and
to file with the Securities and Exchange Commission any schedules or other
filings or amendments thereto made by me pursuant to Section 13(d) of the
Securities Exchange Act of 1934.
IN WITNESS WHEREOF, I have hereunto set my hand this 8th day of September,
1999.
/s/ Stephen N. Joffe
----------------------------
Stephen N. Joffe
EXHIBIT 24.2
POWER OF ATTORNEY
I, SANDRA F.W. JOFFE, hereby appoint GARY P. KREIDER or F. MARK REUTER, or
either of them, as my true and lawful attorney-in-fact to sign on my behalf and
to file with the Securities and Exchange Commission any schedules or other
filings or amendments thereto made by me pursuant to Section 13(d) of the
Securities Exchange Act of 1934.
IN WITNESS WHEREOF, I have hereunto set my hand this 8th day of September,
1999.
/s/ Sandra F.W. Joffe
----------------------------
Sandra F.W. Joffe
